Same receptor, two routes: Cambridge team maps the brain circuits behind obesity drugs
A study from the University of Cambridge has identified distinct brain circuits responsible for the weight loss effects of different obesity drugs. Researchers found that activating the GLP-1 receptor in the brainstem suppresses appetite, while blocking the GIPR receptor in the hypothalamus reduces weight through a separate mechanism. These findings could lead to the design of more effective combination obesity treatments.
EGamers.io
- Entities
- Metabolism
- Neuroscience
- Wegovy
- Ozempic
- Jo Lewis
- MariTide
- Cambridge University
- Zepbound
- Obesity
- Mounjaro
Original source
This article was reported and published by EGamers.io. feed.gg links to it as part of a story cluster — full text, images and rights remain with the publisher.